The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/Objective-Smad4 is a central mediator of transforming growth factor-β/bone morphogenetic protein signaling that controls numerous developmental processes as well as homeostasis in the adult. The present studies sought to understand the function of Smad4 expressed in vascular smooth muscle cells (VSMC) in vascular development and the underlying mechanisms. Methods and Results-Breeding of Smad4 flox/flox mice with SM22α-Cre mice resulted in no viable offspring with SM22α-Cre;Smad4 flox/flox genotype in a total of 165 newborns. Subsequent characterization of 301 embryos between embryonic day (E) 9.5 and E14.5 demonstrated that mice with SM22α-Cre;Smad4 flox/flox genotype died between E12.5 and E14.5 because of decreased cell proliferation and increased apoptosis in the embryonic heart and arteries. Additionally, deletion of Smad4 more specifically in SMC with the inducible smooth muscle myosin heavy chain (SMMHC)-Cre mice, in which decreased cell proliferation was observed only in the artery but not the heart, also caused lethality of the knockout embryos at E12.5 and E14.5. The Smad4-deficient VSMC lacked smooth muscle α-actin filaments, decreased expression of SMC-specific gene markers, and markedly reduced cell proliferation, migration, and attachment. Using specific pharmacological inhibitors and small interfering RNAs, we demonstrated that inhibition of transforming growth factor-β signaling and its regulatory Smad 2/3 decreased VSMC proliferation, migration, and expression of SMC-specific gene markers, whereas inhibition of bone morphogenetic protein signaling only affected VSMC migration. Conclusion-SMC-specific deletion of Smad4 results in vascular defects that lead to embryonic lethality in mice, which may be attributed to decreased VSMC differentiation, proliferation, migration, as well as cell attachment and spreading. The transforming growth factor-β signaling pathway contributes to VSMC differentiation and function, whereas the bone morphogenetic protein signaling pathway regulates VSMC migration. These studies provide important insight into the role of Smad4 and its upstream Smads in regulating SMC function and vascular development of mice. (Arterioscler Thromb Vasc Biol. 2012;32:2171-2177.)
T ransforming growth factor-β (TGF-β) signaling controls a diverse set of cellular processes, including cell proliferation, recognition, differentiation, apoptosis, and determination of developmental fate during embryogenesis and in mature tissues. 1 It not only promotes tissue growth and morphogenesis in the embryo but also activates cytostatic and cell death processes that maintain homeostasis in mature tissues. Disturbances in TGF-β signaling are thus associated with a host of developmental disorders and complex diseases. [2] [3] [4] [5] [6] TGF-β signaling promotes stabilization of blood vessels in multiple ways, including stimulating synthesis and deposition of extracellular matrix components, inducing the differentiation of mesenchymal cells to mural cells, and regulating several cellular processes in both endothelial cells and mural cells. 7, 8 TGF-β signals are transduced through heterodimeric complexes of type I and type II serine/threonine kinase receptors. After formation of the receptor/ligand complex, the type II receptor phosphorylates the type I receptor, which in turn phosphorylates specific members of the receptor-activated Smads (R-Smads). Nearly 30 proteins have been identified as members of the TGF-β superfamily in mammals, and they can be classified based on whether they activate TGF-β-specific R-Smads (Smad 2/3) or bone morphogenetic protein (BMP)specific R-Smads (Smad 1/5/8). Phosphorylated R-Smads associate with the co-Smad, Smad4, and translocate to the nucleus to regulate transcription of target genes. [9] [10] [11] [12] Smad4 encodes the only co-Smad in mammals and is a central mediator of TGF-β and BMP signaling. 13 Several studies using specific deletion of Smad4 in cardiomyocytes and endothelial cells have shown that Smad4 plays essential roles during cardiogenesis, blood vessel remodeling, maturation, and integrity. [14] [15] [16] [17] Nevertheless, the precise role of Smad4 in embryonic development and how it mediates distinct TGF-β/ BMP pathways in regulating proliferation and differentiation of vascular smooth muscle cells (VSMC) is unknown.
The initial step of vessel wall morphogenesis is the formation of a primary vascular network, comprising nascent endothelial cell tubes, via the processes of vasculogenesis and angiogenesis. Subsequently, primordial VSMC are recruited to the endothelium to form a multilayered vessel wall. During the course of development and maturation, the VSMC serves as a biosynthetic, proliferative, and contractile component of the vessel wall. 18 As the vasculature matures, VSMC associate with arteries and veins around which they form multiple concentric layers. Thus, the presence of VSMC provides for vascular tone, control of peripheral resistance, and for distribution of blood flow throughout the developing organism. 19, 20 To determine the role of Smad4 expressed by VSMC in vascular development, we generated SMC-specific Smad4 deletion mice by breeding Smad4-floxed mice with the SM22α-Cre and inducible smooth muscle myosin heavy chain (iSMMHC)-Cre transgenic mice. Deletion of the Smad4 gene by SM22α-cre results in lethality of mice at embryonic day (E) 12.5, attributable to cardiovascular defects. Additionally, SMC-specific deletion of the Smad4 gene by the highly SMC-specific iSMMHC-Cre, which does not affect Smad4 expression in the heart, also causes embryonic lethality at midgestation. VSMC with the Smad4 deficiency displayed a significant reduction in proliferation, migration, cell attachment, and defective actin filament structure. Using specific pharmacological inhibitors and small interfering RNAs, we demonstrated that inhibition of TGF-β signaling and its R-Smads, Smad2 and 3, decreased cell proliferation, migration, and expression of SMC-specific gene markers, whereas inhibition of BMP signaling affected only cell migration.
These data support an important role of the Smad4 gene and its upstream Smads in regulating VSMC phenotype and function, and thus vascular development during mouse embryogenesis.
Materials and Methods
The smooth muscle specific-Smad 4 deletion mice were obtained by crossing the Smad4 flox/flox mice 21 with SM22α-Cre transgenic mice and a highly SMC-specific iSMMHC-Cre transgenic mice. 22 Details of the materials and the experimental procedures are given in the Methods section in the online-only Data Supplement.
Results

Deletion of Smad4 in the Mouse VSMC by SM22α-Cre and iSMMHC-Cre
Gene deletion of Smad4 results in early lethality of Smad4 -/mouse embryos, [23] [24] [25] which precludes further characterization of the role of Smad4 in VSMC in vivo. SMC-specific Smad4 deletion mice were generated by breeding Smad4 flox/flox mice with SM22α-Cre transgenic mice. Male SM22α-Cre;Smad4 flox/+ mice were further crossed with female Smad4 flox/flox mice. Polymerase chain reaction analysis confirmed that Smad4 was efficiently deleted in SMC ( Figure IA in the online-only Data Supplement). Whole-mount LacZ staining for embryos from E8.25 to E11.0 of the SM22α-Cre; ROSA26 double transgenic mice showed that blue-stained cells constituted the heart and dorsal aorta from E8.25 ( Figure IB Because SM22α is transiently expressed in the heart, we further determined the effect of the Smad4 deletion on vascular development by using a highly SMC-specific iSMMHC-Cre mouse model. The Smad4 deletion driven by the iSMMHC-Cre was examined using genomic DNA isolated from embryonic yolk sac, as well as from embryonic heart and vessels. The data demonstrated that Smad4 was specifically deleted in the vessel but not in the heart ( Figure IIA 
Embryonic Lethality in Mice With VSMC-Specific Smad4 Deletion
We did not recover any knockout (SM22α-Cre;Smad4 flox/flox ) neonates from the breeding of male SM22α-Cre;Smad4 flox/+ mice with the female Smad4 flox/flox mice in a total of 165 newborn offsprings, indicating that deletion of Smad4 in VSMC causes embryonic lethality. To determine the stage at which embryonic death occurred, we examined a total of 301 pups from E9.5 to E14.5 (Table) . The percentage of living knockout embryos between E9.5 and E11.5 was not markedly different from the expected ratio (25%) but significantly reduced T Figure 1 . A, Prevalence of the genotype in litters from embryonic day (E) 9.5 to E14.5 and morphological analysis of Smad4deficient embryos. All embryos were genotyped by polymerase chain reaction analysis of the yolk sac, and those with genotype of SM22α-Cre;Smad4 flox/flox were designated as conditional knockout (CKO). B, Gross morphological analysis of embryos from control littermates (a-e) and CKO (f-j) mice at E10.5, E11.5, E12.5, E13.5, and E14.5. Knockout embryos displayed hemorrhaging as indicated with arrow in ventricle at E10.5 and in blood vessel and heart at E11.5 and E12.5 and were absorbed by E13.5 and E14.5.
at E12.5 (11.9% of the total embryos) and further reduced to ≈2.0% and ≈0% at E13.5 and E14.5. None of the knockout embryos survived beyond E14.5 ( Figure 1A) , indicating that the majority of embryonic lethality occurred between E12.5 and E13.5. All surviving and dead knockout embryos displayed internal hemorrhaging ( Figure 1B ), suggesting that the lethality was caused by vascular insufficiency.
As the majority of embryonic lethality occurred at E12.5 and no knockout embryo survived beyond E14.5 with the SM22α-Cre-mediated Smad4 deletion, we specifically evaluated embryo survival at E12.5 and E14.5 with highly SMCspecific iSMMHC-Cre transgene mice. A total of 55 embryos were examined. Because the SMMHC-Cre transgene is located on the Y chromosome, 22 we determined the survival rate of Cre-expressing male embryos. No deaths occurred in the heterozygous embryos with iSMMHC-Cre;Smad4 flox/+ genotype, whereas the survival rate of the knockout embryos with iSMMHC-Cre;Smad4 flox/flox genotype was 54.6% and 56.3% at E12.5 and E14.5 of the total male embryos ( Figure IIC 
Decreased Cell Proliferation and Increased Apoptosis in Smad4-Knockout Artery
To determine the cellular mechanisms that are responsible for the vascular defects, we examined VSMC proliferation by performing immunostaining studies using a primary antibody against phospho-Histone H3. The cell proliferation rate (at E11.5) was reduced ( Figure 2A) , and quantitative analysis confirmed the reduction ( Figure 2B ) in both knockout heart and artery induced by SM22α-Cre. Similarly, a significant reduction of cell proliferation by 57% (at least 1000 nuclei of each section were counted; n=3; P<0.01 compared with that in control embryos) was found in knockout artery induced by iSMMHC-Cre. Importantly, cell proliferation was not affected in the heart of iSMMHC-Cre-mediated Smad4 deletion mice.
Furthermore, terminal deoxynucleotidyl transferase dUTP nick end labeling analysis demonstrated significantly increased cell death in SM22α-Cre-induced knockout heart and artery at E12.5 ( Figure 2C and 2D) . No significant difference in cell death was identified in the heart and artery of iSMMHC-Cre-mediated Smad4 deletion mice (at least 1000 nuclei of each section were counted; n=3; P=0.38 compared with that in control embryos).
Decreased Expression of Smooth Muscle Marker Genes in Smad4-Knockout Mice
Immunostaining with an antibody for α-SMA demonstrated that Smad4 deletion causes a marked decrease of SMA in the dorsa aortas ( Figure 2E ). Furthermore, we performed real-time polymerase chian reaction analysis to compare the expressions of several SMC marker genes in yolk sacs from the Smad4 flox/ flox (control) and SM22α-Cre;Smad4 flox/flox (conditional knockout) mice. Significant reduction of the expression of α-SMA, SM22α, calponin, and SMMHC, as well as the major SMC transcription factors myocardin and serum response factor (SRF), was observed in the knockout mice ( Figure 2F ).
Reduced Proliferation and Migration in VSMC With Smad4 Deletion
To examine whether the loss of Smad4 alters VSMC function, we determined proliferation and migration in vitro in VSMC from Smad4 flox/flox mice that were stably infected with lentivirus (Lenti) green fluorescent protein or Cre. Lenti-green fluorescent protein-infected control VSMC ( Figure 3A [a]) or Lenti-Cre-infected Smad4-knockout VSMC ( Figure 3A [b]) were allowed to migrate through a polycarbonate membrane within 12 hours. Quantitative analysis indicated that the Smad4 deletion in primary VSMC resulted in a significant decrease in migration induced by either 20% fetal bovine serum ( Figure  3C ) or 20 ng/mL platelet-derived growth factor (PDGF) (data not shown). Deletion of Smad4 was confirmed by Western blot analysis ( Figure 3B ). The effect of the Smad4 deletion on cell proliferation in vitro was determined by 5-bromo-2΄deoxyuridine incorporation assays. 5-Bromo-2΄-deoxyuridine labeling showed a 62% decrease in proliferation in Lenti-Cre-stably infected Smad4-knockout VSMC (Lenti-Cre) compared with the control VSMC (Lenti-green fluorescent protein, Figure 3D ). Similar experiments were performed with Smad4 flox/flox VSMC that was transiently infected with Lentigreen fluorescent protein or Lenti-Cre, which also demonstrated that Smad4 deletion caused a significant decrease of proliferation to 52% (n=3) and migration to 40% (n=3).
Decreased Expression of SMC Markers and Disruption of Actin Filament in VSMC With Smad4 Deletion
Immunofluorescent staining with an antibody for α-SMA demonstrated that the Smad4 deletion causes a marked disruption and loss of actin filament ( Figure 3E ). Thus, we determined the effects of the Smad4 deletion on the expression of SMC markers. Significant reduction in the expression of α-SMA, SM22α, calponin, and SMMHC was observed in VSMC with the Smad4 deletion ( Figure 3F ). Furthermore, the expressions of the major SMC transcription factors myocardin and SRF were also decreased ( Figure 3F ).
Decreased VSMC Attachment and Delayed/ Decreased Activation of Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase in VSMC With Smad4 Deletion
In addition, the Smad4 deletion was found to significantly decrease VSMC attachment and spreading ( Figure 4A) . To characterize the possible mechanism involved, we determined Figure 4B ). Quantitative analysis demonstrated that PDGFinduced activation of extracellular signal-regulated kinase, but not p38 or c-Jun N-terminal kinase, was significantly reduced in VSMC with Smad4 deletion ( Figure 4C ).
Inhibition of TGF-β or BMP Signaling Pathways on VSMC Proliferation and Migration
As Smad4 is the key mediator for both TGF-β and BMP signaling pathways, we further determined which upstream signals contribute to the function of Smad4 in regulating VSMC proliferation and migration. Pretreatment of VSMC with a pharmacological inhibitor of TGF-β, SB431542 (10 μmol/L), resulted in a 43% reduction on VSMC proliferation and 67% inhibition on migration, as well as a significant decrease in the expression of SMC marker genes ( Figure 5A-5C ). By contrast, inhibition of BMP signaling by Noggin (100 ng/mL) did not affect cell proliferation or the expression of SMC marker genes but blocked VSMC migration by 91% ( Figure 5B ). The roles of R-Smads of TGF-β signaling pathways, Smad2 and 3, were determined with the use of specific short hairpin RNA for Smad2 and Smad3. Similar to the observation using SB431542, knockdown of Smad2 and 3 significantly reduced VSMC proliferation, migration, and the expression of SMCspecific marker genes ( Figure 6A-6C ).
Discussion
Targeted disruption of Smad4 in mice results in early embryonic lethality with multiple defects in epiblast proliferation, egg cylinder formation, and mesoderm induction. 25 In this study, we determined the role of SMC-expressed Smad4 in vascular development using SMC-specific Smad4 deletion mice. We found that Smad4 deficiency in SMC led to embryonic lethality at E12.5 because of cardiovascular defects, demonstrating an important role of SMC-expressed Smad4 in vascular remodeling and stabilization.
The cardiovascular system is the first organ to develop and function during embryogenesis. A functioning circulatory system is necessary for the transport of nutrients to, and the removal of wastes from, the developing organ systems of the embryo. 26 As the vasculature matures, recruitment and differentiation of VSMC is a critical process. VSMC provide homeostatic control and protect new endothelium-lined vessels against rupture or regression. VSMC also assist endothelial cells in acquiring specialized functions in different vascular beds and in maintaining vascular tone. 27 In the absence of these support cells, some endothelial vessels are hyperplastic, tortuous, dilated, and leaky. In a previous study, specific deletion of the Smad4 in endothelial cells caused embryonic death at an earlier time of E10.5. 14 Our present studies using highly specific SM22α-Cre and SMMHC-Cre transgenic models have demonstrated that deletion of the Smad4 in VSMC, without disturbing endothelium (data not shown), reduces SMC proliferation and differentiation that results in vascular leakage and embryonic lethality at a later stage, E12.5 to E14.5.
SM22α is a calponin-related protein that is expressed exclusively in smooth muscle-containing tissues of adult animals and is one of the earliest markers of differentiated SMCs. 28 In contrast to its smooth muscle specificity in adult tissues, SM22α was first expressed in the heart at E8.25, in the dorsal aorta at E9.5, and in skeletal muscle cells in the myotomal compartment of the somites at E10.5 as indicated with ROSA26 reporter mice used in our system, which is consistent with a previous report. 29 In our study, SM22α-Cremediated deletion of Smad4 did not cause embryonic lethality in mice at such an early stage; however, significant reduction in cell proliferation and increased cell apoptosis were observed in knockout embryonic heart as compared with control littermates at E11.5 and E12.5, suggesting that transient early expression of SM22α in the heart may contribute to the embryonic lethality induced by SM22α-Cre-mediated Smad4 deficiency at midgestation.
Using iSMMHC-Cre mice, a highly SMC-specific transgenic mouse model, we further demonstrated the function of Smad4 deletion in vasculature development. As a highly specific marker for the SMC lineage, SMMHC transcripts were only observed in blood vessels but not in developing brain, heart, or skeletal muscle. 30 Consistently, decreased cell proliferation was only observed in the artery but not in heart of the knockout embryos, which may explain a higher survival rate of iSMMHC-Cremediated knockout embryos at E12.5 and E14.5 compared with SM22α-Cre-mediated deletion of Smad4 at the same stage. Taken together, these results suggest that SMC-specific deletion of Smad4 causes vasculature defect, which leads to embryonic lethality even when heart function is not affected.
We found that Smad4 deletion in VSMC resulted in significant reduction in proliferation, migration, and attachment, which may be attributed to the decreased expression of SMC-specific genes, disrupted actin filament structure, reduced expression of PDGF receptors, and inhibited PDGF-induced activation of extracellular signal-regulated kinase. We found that smooth muscle-specific genes SM22α, calponin, and SMMHC were significantly reduced in VSMC with Smad4 deletion. The principal function of VSMC is contraction and regulation of blood vessel tone, blood pressure, and blood flow. In mature blood vessels, VSMC exhibit a contractile or differentiated phenotype characterized by the expression of contractile markers specific to smooth muscle, including α-SMA, SM22α, calponin, and SMMHC, which are important for the regulation of contraction. 31 Accordingly, it is likely that loss of VSMC contraction, impaired actin filament structure, and reduction of VSMC proliferation and migration because of Smad4 deficiency may be the cause of defects in blood vessel structure and function and thus result in hemorrhaging and embryonic lethality.
Several potential Smad-binding sites have been identified in the promoter regions of the SMC-specific genes. [32] [33] [34] Among the Smad proteins, Smad4, the only co-Smad, plays a critical role in TGF-β-induced SMC-specific gene transcription. In addition, we found that the expression of SRF and myocardin, the key SMC-specific transcription factors, were significantly downregulated in Smad4 knockout mice. SRF has been proposed to be a master regulator of the actin cytoskeleton and contractile apparatus, 35 and myocardin has been reported to be an extraordinarily powerful myogenic SRF coactivator that regulates SMC proliferation and differentiation. 36 Therefore, the reduction of SRF and myocardin by the Smad4 deletion in VSMC contributes to the decreased expression of SMC-specific A, Cells were allowed to attach to coverslips for 5, 10, 20, 30, 60, and 120 minutes, and the attached cells were quantified. The attachment of control cells (lentivrus [Lenti]-GFP) at each time point is defined as 1 (n=3; *P<0.05; **P<0.01). B and C, Cells were exposed to platelet-derived growth factor receptor (20 ng/mL) for 0, 2, 5, 15, 30, and 60 minutes, and Western blot analysis was performed with specific antibodies for ERK, p38, JNK, and their respective phosphorylated isoforms. Representative blots from 3 independent experiments are shown in B. Densitometry analysis of relative phosphorylated-ERK (pERK)/ERK is shown in C, in which the ratio of pERK/ERK in Lenti-GFP cells at 5 minutes was defined as 1 (n=3; *P<0.001). Wild-type VSMC were infected lentiviruses carrying short hairpin RNA (shRNA) for Smad2 or Smad3 to knockdown Smad2 and Smad3, or control scramble shRNA. Quantitative analyses of VSMC (A) proliferation, (B) migration, and (C) SMC-specific marker genes are shown. Cell proliferation, migration, and the expression of marker genes in VSMC infected with control shRNA (sh-Scr) are defined as 1 (n=3; *P<0.05; **P<0.01). α-SMA indicates α-smooth muscle actin; SMMHC, smooth muscle myosin heavy chain; SRF, serum response factor. gene markers, disrupted actin structure, and reduced proliferation and migration of Smad4-deficient VSMC.
The TGF-β superfamily signaling pathways play important roles in regulating SMC differentiation. 8, 37 As Smad4 mediates the majority of both TGF-β and BMP signaling pathways, we further characterized which specific pathway and its corresponding regulatory Smads are important for SMC differentiation. We found that blocking TGF-β significantly decreased cell proliferation and migration, as well as SMC marker expression, whereas only cell migration was affected by blocking BMP signaling. With the use of lenti-short hairpin RNA specific for Smad2 and Smad3, the R-Smads of TGFβ, we have further demonstrated that TGF-β signals, mediated by Smad2 and 3, are the key upstream signals of Smad4 that regulate SMC differentiation, proliferation, and migration.
Taken together, our data suggest that Smad4 participates in a complex regulatory mechanism of midgestation VSMC development, possibly by interacting with multiple smooth musclespecific transcription factors. Smad4 activity is required for proper proliferation, differentiation, and migration of VSMC, which is essential for embryonic vascular development.
